🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Pipeline release! nf-core/bcellmagic v1.1.0 (B cell repertoire analysis pipeline with immcantation framework.) See the changelog: github.com/nf-core/bcellm…

Check out our new preprint, that uses structural analysis to show that the public antibody repertoire may be much larger than previously thought! biorxiv.org/content/10.110… #antibodies #immunology

We're #hiring a Bioinformatician and Bioinformatics Developer at Alchemab Therapeutics Ltd… #bioinformatics lnkd.in/gnpbM5K

Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures biorxiv.org/content/10.110…

The work that we presented at MABRA in january is online now. Many thanks to my co-authors and to Kymab Ltd!

We're #hiring again! A great opportunity to work within a talented team on some unique antibody datasets. We also have some fantastic Scientist/Senior Scientist openings as well - lnkd.in/dsgrBGx lnkd.in/dQwz4Zt

We're excited to announce the release of Parapred-PyTorch! It is a deep learning tool that allows researchers to rapidly predict the probability that a specific CDR position is part of the antibody binding site. github.com/alchemab/parap… (1/n)

Alchemab Therapeutics's tech team are delighted to present our latest pre-print on an antibody-specific language model, AntiBERTa, on bioRxiv! #antibodies #transformers #biotech (1/5) biorxiv.org/content/10.110…

The Alchemab Therapeutics team are excited by the huge growth of BCR repertoire sequencing and analysis! We collected a list of papers in this space – feel free to share and contribute👍 #BCRs #antibodies #papers #datasets #machinelearning github.com/alchemab/bcr-r…

Really excited to announce that AntiBERTa is now published in Patterns, a Cell Press journal! Here we describe a transformer model that demonstrates understanding of antibody sequences 🧵 (1/6) #machinelearning #antibodies #drugdiscovery cell.com/patterns/fullt…

Looking forward to talking more about the Alchemab platform at #AIRRC6

Excited to be presenting Kymab’s IntelliSelect poster at #AIRR2017

Collaborate with Cerevance, Kymab Ltd, Immunocore, Novo Nordisk as part of our fully funded iCASE #PhD studentship. Find out more about the available projects and apply medsci.ox.ac.uk/study/graduate…

Bioinformatician & Front-End Developer, Kymab Ltd, Cambridge, UK ift.tt/2IeH8rG